🇺🇸 FDA
Pipeline program

Spinraza 12 mg solution for injection

232SM404

Approved small_molecule active

Quick answer

Spinraza 12 mg solution for injection for Spinal Muscular Atrophy is a Approved program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Biogen Idec Ltd
Indication
Spinal Muscular Atrophy
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials